Anti-Ikaros antibody [EPR13791] - C-terminal
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Ikaros antibody. C-terminal. Suitable for WB, ICC/IF, Flow Cyt (Intra), IP and reacts with Human samples. Cited in 1 publication.
View Alternative Names
IK1, IKAROS, LYF1, ZNFN1A1, IKZF1, DNA-binding protein Ikaros, Ikaros family zinc finger protein 1, Lymphoid transcription factor LyF-1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Ikaros antibody [EPR13791] - C-terminal (AB190691)
Intracellular Flow Cytometry analysis of Jurkat (human acute T cell leukemia) labelling Ikaros with purified ab190691 at 1/60 (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Alexa Fluor® 488 goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Ikaros antibody [EPR13791] - C-terminal (AB190691)
Immunofluorescent analysis of 4% paraformaldehyde fixed Jurkat cells labeling Ikaros with ab190691 at 1/250 followed by Goat anti rabbit IgG (Alexa Fluor® 555) at 1/200 and conterstained with DAPI.
- IP
Lab
Immunoprecipitation - Anti-Ikaros antibody [EPR13791] - C-terminal (AB190691)
50-70 kDa Ikaros was immunoprecipitated from 0.35mg Ramos (human Burkitt's lymphoma B lymphocyte) whole cell lysate with ab190691 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab190691 at 1/1000 dilution (0.71 μg/ml). VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution. Lane 1 (Input) : Ramos (human Burkitt's lymphoma B lymphocyte) whole cell lysate 10 μg. Lane 2 (+) : Ramos whole cell lysate. Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab190691 in Ramos whole cell lysate. Blocking buffer and concentration : 5% NFDM/TBST. Diluting buffer and concentration : 5% NFDM/TBST. Exposure time : 15 seconds.
All lanes:
Immunoprecipitation - Anti-Ikaros antibody [EPR13791] - C-terminal (ab190691) at 1/30 dilution
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 57 kDa
Observed band size: 50-70 kDa
false
Exposure time: 15s
- WB
Lab
Western blot - Anti-Ikaros antibody [EPR13791] - C-terminal (AB190691)
Lanes 1 - 4 : Merged signal (red and green). Green - ab190691 observed at 50-70 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab190691 was shown to react with Ikaros in wild-type Jurkat cells in western blot with loss of signal observed in IKZF1 knockout sample. Wild-type and IKZF1 knockout Jurkat cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab190691 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Ikaros antibody [EPR13791] - C-terminal (ab190691) at 1/1000 dilution
Lane 1:
Wild-type Jurkat cell lysate at 20 µg
Lane 2:
IKZF1 knockout Jurkat cell lysate at 20 µg
Lane 3:
Daudi cell lysate at 20 µg
Lane 4:
HeLa cell lysate at 20 µg
Predicted band size: 57 kDa
Observed band size: 50-70 kDa
false
- WB
Supplier Data
Western blot - Anti-Ikaros antibody [EPR13791] - C-terminal (AB190691)
All lanes:
Western blot - Anti-Ikaros antibody [EPR13791] - C-terminal (ab190691) at 1/10000 dilution
Lane 1:
Raji cell line lysate at 20 µg
Lane 2:
Jurkat cell line lysate at 20 µg
Lane 3:
Ramos cell line lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated antibody at 1/1000 dilution
Predicted band size: 57 kDa
Observed band size: 50-70 kDa
false
Related conjugates and formulations (8)
-
Anti-Ikaros antibody [EPR13791] - BSA and Azide free
-
660 APC
APC Anti-Ikaros antibody [EPR13791] (C-terminal)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Ikaros antibody [EPR13791] - C-terminal
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Ikaros antibody [EPR13791] - C-terminal
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Ikaros antibody [EPR13791] - C-terminal
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Ikaros antibody [EPR13791] - C-terminal
-
578 PE
PE Anti-Ikaros antibody [EPR13791] (C-terminal)
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Ikaros antibody [EPR13791] - C-terminal
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Ikaros protein functions in the regulation of lymphoid cell development. It is a part of a chromatin-remodeling complex influencing chromatin accessibility. Through its zinc finger domains it binds to specific DNA sequences controlling genes necessary for lymphocyte differentiation and proliferation. Ikaros influences various cell types within the immune system especially affecting T and B cell development and also regulates cytokine receptor genes necessary for proper immune function.
Pathways
The Ikaros protein is critical to lymphocyte signaling pathways particularly the JAK/STAT and NF-κB pathways. In these pathways Ikaros interacts with other transcription factors like GATA3 and STAT5 integrating signals that are important for immune cell function and development. This integration allows a coordinated response to extracellular signals ensuring effective immune responses or tolerance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
The Journal of cell biology 219: PubMed31757787
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com